Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | SGN-MesoC2 |
| Trade Name | |
| Synonyms | SGN MesoC2|SGNMesoC2|PF08052666|PF 08052666|PF08052666|HBM9033 |
| Drug Descriptions |
SGN-MesoC2 is an antibody-drug conjugate (ADC) comprising an anti-MSLN antibody linked to a camptothecin-based topoisomerase I inhibitor, which potentially induces cytotoxicity in MSLN-expressing tumor cells and antitumor activity (Cancer Res (2025) 85 (8_Supplement_1): 324). |
| DrugClasses | MSLN Antibody 13 |
| CAS Registry Number | NA |
| NCIT ID | C210446 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| SGN-MesoC2 | SGN-MesoC2 | 0 | 1 |